Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis.
Saved in:
| Title: | Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis. |
|---|---|
| Authors: | Afferi L; Harvard T. H. Chan School of Public Health, Boston, MA, USA. luca.afferi@gmail.com.; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. luca.afferi@gmail.com.; Department of Urology, Fundació Puigvert, Barcelona, Spain. luca.afferi@gmail.com., Jahn B; Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Hall in Tirol, Austria., Kelkar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Dijk SW; Department of Radiology and Nuclear Medicine, Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands., Feldman ZM; Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA, USA., Ward ZJ; Center for Health Decision Science, Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Moschini M; Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Cathomas R; Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland., Bellmunt J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Parc de Salut Mar, Hospital del Mar Medical Research Institute, Barcelona, Spain., Gallioli A; Department of Urology, Fundació Puigvert, Barcelona, Spain., Breda A; Department of Urology, Fundació Puigvert, Barcelona, Spain., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Mattei A; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Chang SL; Harvard Medical School, Boston, MA, 02215, USA.; Division of Urologic Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA., Siebert U; Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Hall in Tirol, Austria.; Center for Health Decision Science, Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Program on Cardiovascular Research, Institute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA. |
| Source: | World journal of urology [World J Urol] 2025 Mar 30; Vol. 43 (1), pp. 197. Date of Electronic Publication: 2025 Mar 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40159560 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Afferi+L%22">Afferi L</searchLink>; Harvard T. H. Chan School of Public Health, Boston, MA, USA. luca.afferi@gmail.com.; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. luca.afferi@gmail.com.; Department of Urology, Fundació Puigvert, Barcelona, Spain. luca.afferi@gmail.com.<br /><searchLink fieldCode="AU" term="%22Jahn+B%22">Jahn B</searchLink>; Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Hall in Tirol, Austria.<br /><searchLink fieldCode="AU" term="%22Kelkar+AH%22">Kelkar AH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Dijk+SW%22">Dijk SW</searchLink>; Department of Radiology and Nuclear Medicine, Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Feldman+ZM%22">Feldman ZM</searchLink>; Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ward+ZJ%22">Ward ZJ</searchLink>; Center for Health Decision Science, Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moschini+M%22">Moschini M</searchLink>; Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Cathomas+R%22">Cathomas R</searchLink>; Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bellmunt+J%22">Bellmunt J</searchLink>; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Parc de Salut Mar, Hospital del Mar Medical Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gallioli+A%22">Gallioli A</searchLink>; Department of Urology, Fundació Puigvert, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Breda+A%22">Breda A</searchLink>; Department of Urology, Fundació Puigvert, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fankhauser+CD%22">Fankhauser CD</searchLink>; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mattei+A%22">Mattei A</searchLink>; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chang+SL%22">Chang SL</searchLink>; Harvard Medical School, Boston, MA, 02215, USA.; Division of Urologic Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Siebert+U%22">Siebert U</searchLink>; Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Hall in Tirol, Austria.; Center for Health Decision Science, Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Program on Cardiovascular Research, Institute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228307716%22">World journal of urology</searchLink> [World J Urol] 2025 Mar 30; Vol. 43 (1), pp. 197. <i>Date of Electronic Publication: </i>2025 Mar 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8307716 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1433-8726 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207244983%22">07244983 </searchLink><i>NLM ISO Abbreviation: </i>World J Urol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40159560 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00345-025-05584-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 197 Titles: – TitleFull: Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Afferi L – PersonEntity: Name: NameFull: Jahn B – PersonEntity: Name: NameFull: Kelkar AH – PersonEntity: Name: NameFull: Dijk SW – PersonEntity: Name: NameFull: Feldman ZM – PersonEntity: Name: NameFull: Ward ZJ – PersonEntity: Name: NameFull: Moschini M – PersonEntity: Name: NameFull: Cathomas R – PersonEntity: Name: NameFull: Bellmunt J – PersonEntity: Name: NameFull: Gallioli A – PersonEntity: Name: NameFull: Breda A – PersonEntity: Name: NameFull: Fankhauser CD – PersonEntity: Name: NameFull: Mattei A – PersonEntity: Name: NameFull: Chang SL – PersonEntity: Name: NameFull: Siebert U IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 03 Text: 2025 Mar 30 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1433-8726 Numbering: – Type: volume Value: 43 – Type: issue Value: 1 Titles: – TitleFull: World journal of urology Type: main |
| ResultId | 1 |